BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16202771)

  • 1. Assessing the cost of cystic fibrosis diagnosis and treatment.
    Rosenberg MA; Farrell PM
    J Pediatr; 2005 Sep; 147(3 Suppl):S101-5. PubMed ID: 16202771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the costs of diagnosing cystic fibrosis with a newborn screening program.
    Lee DS; Rosenberg MA; Peterson A; Makholm L; Hoffman G; Laessig RH; Farrell PM
    J Pediatr; 2003 Jun; 142(6):617-23. PubMed ID: 12838188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of 4 neonatal screening strategies for cystic fibrosis.
    van den Akker-van Marle ME; Dankert HM; Verkerk PH; Dankert-Roelse JE
    Pediatrics; 2006 Sep; 118(3):896-905. PubMed ID: 16950979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost of care and clinical condition in paediatric cystic fibrosis patients.
    Baumann U; Stocklossa C; Greiner W; von der Schulenburg JM; von der Hardt H
    J Cyst Fibros; 2003 Jun; 2(2):84-90. PubMed ID: 15463855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence on improved outcomes with early diagnosis of cystic fibrosis through neonatal screening: enough is enough!
    Farrell PM; Lai HJ; Li Z; Kosorok MR; Laxova A; Green CG; Collins J; Hoffman G; Laessig R; Rock MJ; Splaingard ML
    J Pediatr; 2005 Sep; 147(3 Suppl):S30-6. PubMed ID: 16202779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes.
    Sontag MK; Hammond KB; Zielenski J; Wagener JS; Accurso FJ
    J Pediatr; 2005 Sep; 147(3 Suppl):S83-8. PubMed ID: 16202790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing.
    Rock MJ; Hoffman G; Laessig RH; Kopish GJ; Litsheim TJ; Farrell PM
    J Pediatr; 2005 Sep; 147(3 Suppl):S73-7. PubMed ID: 16202788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost effectiveness of newborn screening for cystic fibrosis: a simulation study.
    Nshimyumukiza L; Bois A; Daigneault P; Lands L; Laberge AM; Fournier D; Duplantie J; Giguère Y; Gekas J; Gagné C; Rousseau F; Reinharz D
    J Cyst Fibros; 2014 May; 13(3):267-74. PubMed ID: 24238947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newborn screening for cystic fibrosis. The Cystic Fibrosis Neonatal Screening Study Group.
    Farrell PM; Mischler EH
    Adv Pediatr; 1992; 39():35-70. PubMed ID: 1442316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal pulmonary status of cystic fibrosis children with meconium ileus.
    Li Z; Lai HJ; Kosorok MR; Laxova A; Rock MJ; Splaingard ML; Farrell PM
    Pediatr Pulmonol; 2004 Oct; 38(4):277-84. PubMed ID: 15334503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications associated with symptomatic diagnosis in infants with cystic fibrosis.
    Accurso FJ; Sontag MK; Wagener JS
    J Pediatr; 2005 Sep; 147(3 Suppl):S37-41. PubMed ID: 16202780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing early, prolonged vitamin E deficiency: an opportunity for better cognitive outcomes via early diagnosis through neonatal screening.
    Koscik RL; Lai HJ; Laxova A; Zaremba KM; Kosorok MR; Douglas JA; Rock MJ; Splaingard ML; Farrell PM
    J Pediatr; 2005 Sep; 147(3 Suppl):S51-6. PubMed ID: 16202783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A survey of newborn screening for cystic fibrosis in Europe.
    Southern KW; Munck A; Pollitt R; Travert G; Zanolla L; Dankert-Roelse J; Castellani C;
    J Cyst Fibros; 2007 Jan; 6(1):57-65. PubMed ID: 16870510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm.
    Parad RB; Comeau AM
    J Pediatr; 2005 Sep; 147(3 Suppl):S78-82. PubMed ID: 16202789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innovative assessment of inpatient and pulmonary drug costs for children with cystic fibrosis.
    Levy JF; Rosenberg MA; Farrell PM
    Pediatr Pulmonol; 2016 Dec; 51(12):1295-1303. PubMed ID: 27740724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life of children with cystic fibrosis.
    Koscik RL; Douglas JA; Zaremba K; Rock MJ; Splaingard ML; Laxova A; Farrell PM
    J Pediatr; 2005 Sep; 147(3 Suppl):S64-8. PubMed ID: 16202786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the costs of care for cystic fibrosis: an analysis by age and health state.
    van Gool K; Norman R; Delatycki MB; Hall J; Massie J
    Value Health; 2013; 16(2):345-55. PubMed ID: 23538187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost of home and hospital care for patients with cystic fibrosis followed up in two reference medical centers in France.
    Horvais V; Touzet S; François S; Bourdy S; Bellon G; Colin C; Durieu I
    Int J Technol Assess Health Care; 2006; 22(4):525-31. PubMed ID: 16984688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newborn screening for cystic fibrosis.
    Rock MJ
    Clin Chest Med; 2007 Jun; 28(2):297-305. PubMed ID: 17467549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal screening for cystic fibrosis: an economic analysis.
    Nielsen R; Gyrd-Hansen D
    Health Econ; 2002 Jun; 11(4):285-99. PubMed ID: 12007162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.